|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07K 14/545 | (2006.01) |
| A61P 19/02 | (2006.01) | ||
| A61K 38/20 | (2006.01) |
| (11) | Patento numeris | 3470421 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18191564.6 |
| Europos patento paraiškos padavimo data | 2011-07-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-04-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 36879910 P | 2010-07-29 | US | |
| 201161436178 P | 2011-01-25 | US | |
| 201161436184 P | 2011-01-25 | US | |
| 201161493966 P | 2011-06-06 | US | |
| 201161493967 P | 2011-06-06 | US |
| (72) |
BARNES, Thomas M. , US
HOU, Jinzhao , US
KING, Bracken M. , US
|
| (73) |
Buzzard Pharmaceuticals AB ,
Skeppsbron 16, 111 30 Stockholm,
SE
|
| (54) | CHIMERIC IL-1 RECEPTOR TYPE I ANTAGONISTS |
| CHIMERIC IL-1 RECEPTOR TYPE I ANTAGONISTS |